-
Telling Their Stories Through PostersSurvivors and advocates display their posters alongside the work of thousands of cancer researchers.
by Kevin McLaughlin
-
The Crowded Field of Checkpoint InhibitorsDrug developers behind currently approved checkpoint inhibitors discuss the pros and cons of competition in the field.
by Kate Yandell
-
Risk Reduction, Clinical Trials Are Focus of Atlanta Community EventCancer researchers, patient advocates and community members gathered for a public forum presented by the American Association for Cancer Research.
by Kevin McLaughlin
-
March 29: The Week in Cancer NewsJury awards damages to man who says Roundup caused his cancer, the FDA proposes national standards for breast density notifications, and a physician questions whether patients with impaired renal function should avoid contrast-enhanced scans.
by Marci A. Landsmann
-
Policy Matters
Eliminating HPV-Related CancerHPV vaccination and screening can help eradicate cervical cancer and other malignancies.
by Anna R. Giuliano, PhD
-
More Options for Rare CancersPrecision medicine and immunotherapy offer opportunities for new treatments and clinical trials to patients who previously had few, if any, options.
by Kendall K. Morgan
-
The Patient PerspectivePatient-reported outcomes may help shape the future of cancer care.
by Stephen Ornes
-
Get Involved
Happy CampersChildren affected by a parent's cancer get a unique summer camp experience at Camp Kesem.
by Hanna Greeman
-
Forward Look
Cancer Patients Can Now Defer Student LoansPayments can be put off during treatment and for six months after.
by Bradley Jones
-
Young Colorectal Cancer Patients Are Often MisdiagnosedA new survey suggests that young adults with colorectal cancer struggle to receive an accurate, prompt diagnosis.
by Bradley Jones
Reports on breast density inform women of their status but raise questions about what to do next.
by Robin Roenker
Injection Immunotherapies Get FDA ApprovalGiving immunotherapy drugs as injections, rather than intravenously, means patients can spend less time in the hospital or treatment center.
by Laura Gesualdi-Gilmore
Designing Clinical Trials for the PatientChallenges in developing and studying treatments call for new ways of thinking about cancer research.
by Eric Fitzsimmons
Treating Smoldering Multiple MyelomaA monoclonal antibody drug reduced the risk of smoldering myeloma progressing to multiple myeloma in patients at high risk for disease progression.
by Sandra Gordon
-
AACR IO: Revolutionizing Treatment through ImmunotherapyThe AACR’s immuno-oncology meeting brings together the leading experts in immunotherapy to accelerate progress in cancer science and medicine.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
